OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2022-03-31-accounts

REGISTERED COMPANY NUMBER: 02057706 (England and Wales) REGISTERED CHARITY NUMBER: 295384

FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST MARCH 2022

FOR

DRUGLINK (A COMPANY LIMITED BY GUARANTEE)

Haines Watts (Berkhamsted) Limited 4 Claridge Court Lower Kings Road Berkhamsted Hertfordshire HP4 2AF

DRUGLINK

CONTENTS OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST MARCH 2022

Page
Reference and Administrative Details 1
Chairman's Statement 2
Report of the Trustees 3 to 12
Report of the Independent Auditors 13 to 16
Statement of Financial Activities 17
Balance Sheet 18
Cash Flow Statement 19
Notes to the Cash Flow Statement 20
Notes to the Financial Statements 21 to 30
Detailed Statement of Financial Activities 31 to 32

DRUGLINK

REFERENCE AND ADMINISTRATIVE DETAILS FOR THE YEAR ENDED 31ST MARCH 2022

TRUSTEES

D J Swarbrick Chairman P M Dowd K Cohen R Knowles J R P Conolly R Busse-Reid J Sharp (appointed 22/6/2022) N Pedrithes (appointed 22/6/2022) A Welsh (resigned 31/8/2021)

COMPANY SECRETARY D Heath

REGISTERED OFFICE Trefoil House Red Lion Lan Hemel Hempstead Hertfordshire HP3 9TE

REGISTERED COMPANY 02057706 (England and Wales) NUMBER REGISTERED CHARITY 295384 NUMBER

SENIOR STATUTORY AUDITOR Shaun Brownsmith FCA

AUDITORS

Haines Watts (Berkhamsted) Limited 4 Claridge Court Lower Kings Road Berkhamsted Hertfordshire HP4 2AF

Page 1

DRUGLINK

CHAIRMAN'S STATEMENT FOR THE YEAR ENDED 31ST MARCH 2022

Whilst the financial results for the year ending 31st March 2022 are disappointing, especially compared with the excellent year Druglink enjoyed in the previous year the Charity did make progress during the year. The small deficit (£10,509) this year compared with the marked surplus (£183,467) in the previous year is largely due to two factors. Firstly the 'lockdown' financial support received in 2020 was not repeated in 2021 and secondly the supported housing element of Druglink's operations encountered some financial difficulties, resulting in a small deficit.

During the year, management have taken action to improve the financial performance of our supported housing operation that we believe will have a positive impact on this year's financial performance. In addition much needed investment in our IT provision was made during 21/22. We expect that the improved efficiency resulting from the IT upgrades, together with our extended supported housing offering should allow the Charity to return to a positive financial position in the current year.

Emerging from the pandemic, however it is apparent that significant 'substance abuse' problems exist in society and it is anticipated that public spending associated with reducing the impacts of substance abuse will increase. Druglink is therefore anticipating an increase in demand for its 'recovery' interventions (detox and rehabilitation) and is currently developing plans to increase and extend its capabilities in this area.

Overall, we expect that the next few years will bring an increase in demand for our services together with an increase in funds available to provide those services. We believe that we have a management aligned with the needs of the sector, a workforce equipped and focussed to provide help and support for people affected by such problems and with our planned developments in facilities we are well placed to enjoy success over the medium term.

Page 2

DRUGLINK

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31ST MARCH 2022

The Trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31 March 2022. The Trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).

OBJECTIVES AND ACTIVITIES

Objectives and aims

In reviewing our aims and objectives and planning our future activities Druglink has referred to the guidance in the Charity Commission's general guidance on public benefit. In particular, the Trustees consider how planned activities will contribute to the aims and objectives they have set out in our Strategy. Through our pathway, Druglink offers benefit to the community through the prevention of, and recovery from, substance misuse.

Our objective is to change the future for people who are, or could be, affected by substance misuse. We achieve this through Addiction Treatment, Housing Solutions, Education and Training.

We Change Futures

Prevention - Our Diversion Schemes and educational activities, such as school presentations and community engagements, present risk factors associated with substance misuse. Druglink takes an active role in education to help prevent substance misuse; we believe that by making the realities of substance misuse and addiction more visible we enable people to make better decisions about their substance use. Better education results in greater awareness and understanding of addiction, which enables us to help more people in their recovery journey as well as working towards reducing drug and alcohol related issues in local communities.

Recovery - Druglink's Oxygen Recovery Service offers a person-based treatment programme to people with drug and alcohol addictions and dependencies. Our service offers individuals the opportunity to address their addictions in a supportive and therapeutic environment with programmes based on the needs of individuals. Our service works closely with the other agencies and counselling services which are offered to the clients and their partners and families. Our Oxygen Recovery service provides flexible levels of housing support depending on an individual's needs and where they are within their treatment journey.

Re-integration and Independent Living - Our housing service provides secure supported community living to those in recovery from substance misuse issues. We provide structured programmes including volunteering on projects that provide education and training opportunities, build skills, self-confidence and self-esteem and help individuals reintegrate into local communities.

Activities

2021/22 has been a period of rebuilding for Druglink following the effects of the COVID-19 pandemic. Our education and training services were run completely remotely during 2020/21 and our rehab and detox services required complete redesign to ensure the health and safety of our staff and clients.

2021/22 has allowed us to cautiously re-connect with our clients and students and re-start the process of meeting people 'in person'. This has presented us with some challenges as we have taken this opportunity to rethink and redesign our work, to update and rebuild.

We believe that our work really does 'Change Futures' for those we connect with and the activity presented in this report shows that during 2021 we have done our best, we have supported each other and we have 'done the right thing'.

Page 3

DRUGLINK

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31ST MARCH 2022

OBJECTIVES AND ACTIVITIES Druglink Service Review

Oxygen

Housing

Oxygen Recovery Service and Oxygen Breathe

Oxygen Recovery is a nine-bed rehabilitation and detoxification service offering support for those suffering from alcohol and drug addiction in a therapeutic environment. Clients receive one-to-one support as well as group therapy and relapse prevention advice. Groups once again included anger management, assertiveness, yoga, art and group therapy. The average stay is twelve weeks though some clients stay up to six months. The shortest rehab stay offered is 28 days with the client being able to access aftercare with telephone support and weekly visits. We work with clients who have complex needs and offer client-centred holistic support.

The number of people who received treatment at Oxygen between April 2021 and the end of March 2022 was 82 (an increase of 5 on the previous year) with 50 detox treatments and 32 rehab treatments provided. The majority of clients were in treatment following use of Class A drugs or alcohol. The majority of our clients identified as male.

Our quality data showed an improvement last year. In clients' surveys when asked "Do you feel you received a high level of overall service at Oxygen Recovery", the number who responded "Yes Generally" or "Yes, Definitely" was 98% (a 7% increase on the previous year). Information from clients' exit questionnaires showed that when asked, "How well do you feel your needs are being met on an emotional and psychological level", 100% responded with either "Good" or "Excellent" (another 7% increase on 2020).

Oxygen Recovery offers aftercare for up to six months with clients having access to telephone or one-to-one support. If they move onto our supported living facilities, we also offer them the chance to attend the service and all of the available support groups. This ensures that people are leaving their rehabilitation with the knowledge that in their early days of recovery, when they are most likely to relapse, they can continue to access immediate help and support.

Oxygen's excellent outcomes and associated reputation has allowed us to be included in another three framework arrangements with local authorities during the year. We will now be able to support clients from three more areas in the Midlands.

During 2020/21 we introduced a new software package, 'Inform' into Oxygen. Staff use this software to measure a client's progress and it has greatly improved the record keeping processes. It also allows much better recording and understanding of our clients' and highlights simply and quickly the areas that we need to continue to work at.

"I want to thank you for all your hard work and dedication. You are all one of the main reasons I'm alive, I will be forever grateful and I bet you don't even realise it! I honestly didn't believe I would last a week there never mind graduate and stay sober! You made me feel so welcome from the moment I walked in to the second I walked out. You will always have a special place in my heart."

An Oxygen client

Page 4

DRUGLINK

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31ST MARCH 2022

Oxygen Choices

Our Oxygen Choices programme offers 30 beds of supported housing for those in recovery - an increase of 7 from the previous year. We have had 70 clients in our Oxygen Choices service this year who then are given floating support and attend our day service at Trefoil House. We partner with other agencies offering specialist advice for those looking to move on into education, training and employment.

Page 5

DRUGLINK

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31ST MARCH 2022

OBJECTIVES AND ACTIVITIES

We help service users by offering them the 'Choices' group program that consists of relapse prevention, tenancy skills support, process groups and complimentary services. We educate people on substances and their effects in order to drive prevention and stop problems arising in the future. We also offer housing related support, conduct weekly keywork sessions that focus on support plans and risk management plans. Choices' clients also benefit from the inclusion of external stakeholders in the service and we have improved and included family members, wherever that is possible, as this has been shown to be beneficial in a client's recovery.

Oxygen Gateway and Housing First

Oxygen Gateway has eleven beds of supported accommodation for anyone with a history of offending, substance misuse or homelessness. Clients are encouraged to move on as soon as they are ready and they can continue to receive informal support after leaving Druglink. During the past year clients have commented on the importance of this opportunity to have stable accommodation from which to restart their lives.

We have further developed our partnership with other drug and alcohol services to provide a holistic approach to recovery and have worked with the Workability team to help improve the chances of residents gaining employment. At the end of the year we relocated the entire project from Hatfield to Hemel Hempstead where we can offer an improved quality of housing as well as making it easier for clients to access our day services at Trefoil House. Whilst this proved to be a catalyst for many clients to move on it has been an opportunity for us to introduce new clients into the service with improved structure and support.

Our Housing First project has continued to grow and provide support to tenants on their journey away from homelessness. During 2021/22 we expanded the Housing First service which now offers 9 places of supported housing to our client group that has included entrenched street drinkers, clients who are actively injecting and clients with problematic sex working histories.

Gateway Eve

Gateway Eve offers three bedrooms of supported accommodation for females with a history of offending related to substance misuse. The service is available to low to medium risk offenders with clients able to stay at the property for between 12 and 52 weeks. Gateway Eve continues to operate at high levels of occupancy with a waiting list.

Our specialist Recovery Worker is based on site supporting the clients to make good decisions about their health and welfare and helping them to reintegrate into the local community.

General Activity

Druglink continue to provide floating support to residents who move on to other tenancies. We have continued to work with a group over the past year giving intensive support to clients to:

We will continue to improve our offer to clients introducing 'tenancy maintenance' skills and moving them on to appropriate secure accommodation. Our Housing First project uses the Homelessness Star to prove to partners the value and the success of the service.

Diversion Courses

During the year to 31 March 2022, Druglink have continued to provide our national Diversion education and awareness sessions in partnership with 18 Police forces across the UK. Diversion courses provide an early intervention for people who have committed an alcohol-related or drugs-related offence. These 'Out of Court Disposals' (OoCDs) - usually a Conditional Caution or a Community Resolution - provide a Diversionary intervention which encourages offenders to examine their actions and promotes more responsible behaviour to reduce the chances of future offending.

Our courses give offenders important information that can help them:

Page 6

DRUGLINK

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31ST MARCH 2022

OBJECTIVES AND ACTIVITIES

Although our courses are aimed at first time offenders they are designed to be hard-hitting; they challenge and confront whilst also informing and educating. Our trainers tailor their approach to each group to ensure that participants are engaged and get the most from their session.

During the year, we have had 14,031 people referred to courses from our Police partners which represents a 65% increase on the previous year. Around 63% of referrals were for our Cannabis courses and 19% for alcohol courses with around 75% being Community Resolutions.

During September we restarted our face to face courses across the country. We received a grant from the National Lottery 'Awards for All' fund to ensure that our IT equipment was suitable for the improved courses that we had devised. We also recruited a new group of Trainers to deliver our courses in each location. We provided all of the trainers with Training Packs and an 'induction day' to ensure that they deliver our courses uniformly across all areas of the country.

In November we launched a 'whole person' pilot project with Thames Valley Police. This consisted of trialling a new approach which saw offenders referred to us having a 'triage' interview with one of our expert staff who could then signpost them most appropriately towards the agency that could help them most. A total of 632 passed through the service to the end of March 2022 with the majority being offered one of our Diversion courses along with a tailored support pathway to help them towards recovery.

We maintained our Hardship Fund which provides financial assistance to those who need to undertake the course but who cannot afford the cost. During this year we have supported an increasing number of clients to complete the course using our Hardship Fund to meet the cost. Police forces across the country are now recognising the importance of this fund and several forces are now operating a similar fund.

Communications and Marketing

Good Neighbours Initiative

One of Druglink's key aims continues to be acting as good neighbours to our local community. We are particularly proud of our work with Kings Langley Football Club who have continued to be active supporters during the past year. They have raised a considerable sum of money to support us this year and we are partnering with them again during 2022. Druglink will be delivering a tailored education programme to the club's members throughout the year with the aim of increasing knowledge and understanding of the dangers of Drugs and Alcohol and enabling them to make informed decisions about their use.

We have also continued our work with Kings Langley School, delivering awareness sessions to staff and pupils. Pupils voted that Druglink should be the recipient of money raised from their annual sponsored walk event which was particularly important to us.

In early 2022 Druglink became the charity partners in a local Hemel Hempstead business network which works to support local businesses in developing their enterprise. Whilst we are still fledgling members of the group we are already benefitting from the extended links this network gives us.

Coffee Ethic

Coffee Ethic has made a gradual return following the pandemic closure. The Civic Centre location has proved to be limiting as many members of staff are still working from home therefore reducing the footfall to the cart. Despite this we have continued to train a small number of clients on the cart and we are continuing to support the development of this activity.

Our Charity

In order to meet our charitable objectives most effectively we need to be an efficient and effective organisation. During 2021/22 we have continued to invest in making the Charity a good and efficient place to work.

Page 7

DRUGLINK

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31ST MARCH 2022

OBJECTIVES AND ACTIVITIES

In April we introduced a Spinal Column Point structured pay system. This is designed to see staff appointed and paid in an equitable manner that reflects their experience and qualifications. The SCP system also allows staff to see a pay progression linked to their annual appraisal and incentivises staff to meet their targets and invest in their own development.

During 2021 we finally moved our remaining legacy systems to a cloud-based operating system. We have introduced 'Sharepoint' across the charity which has improved communication and the management of documents.

Our staff team have, as always, been amazing over the past year. Our Staff team have coped with the difficulties faced in running services for clients during a period of intense uncertainty. Staff have consistently gone 'above and beyond' what is expected of them because of the personal commitment to our clients that they bring with them into work every day.

Druglink believes that we Change Futures for people. Our activity across all of our services and throughout our organisation during 2021/22 has underlined our determination to Change Futures through our charitable work.

Page 8

DRUGLINK

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31ST MARCH 2022

FINANCIAL REVIEW

Financial and Operations Review

The Financial Statements for the year ended 31 March 2022 show a deficit for the year of £10,509 (2021:surplus £183,467) with positive reserves at the year-end of £85,925 (2021: positive reserves of £96,434).

Income

Druglink receives income from a number of different sources and the total income for the year was £1,547,335 (2021: £1,484,660). Druglink continues to receive funding in return for delivering and managing a number of contracted services including:

Druglink generated income through its other activities and sources, of which the key ones were:

Expenditure

Expenditure for the year was £1,557,844 (2021: £1,301,193). The largest expenditure item for the organisation is staff costs which accounted for 50% (2021: 46%) of total expenditure. These staff provide essential services to our clients and are experienced individuals from a variety of backgrounds enabling Druglink to offer a rounded service to its clients.

Investment policy

Druglink had no financial investments at the year end. The Trustees keep any surplus cash in deposit accounts while being mindful of the financial services compensation scheme limits. There are no current plans to invest beyond this approach.

Reserves

The Trustees have reviewed the reserves policy and decided that £250,000 of general reserves is appropriate for approximately 3 to 6 months of committed operating expenditure. Currently the charity has a low level of reserves and endeavours to continue to build on these existing reserves to this level through our activities.

Page 9

DRUGLINK

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31ST MARCH 2022

Bounce Back Loan

The charity availed of a Bounce Back loan during the prior year to support its liquidity position following two years of negative results and to ensure that it continued to provide its various services, This loan is planned to be repaid over five years in accordance with the UK Government terms commencing during May 2021.

FUTURE PLANS

The charity intends to continue and carefully grow its existing activities subject to adequate funding being available.

Oxygen and Housing

Our focus is to continue to provide high quality services against a background of maintaining high levels of occupancy and thereby ensuring that each activity house is providing a surplus. This is a core focus to enable us to continue to recover from the deficits of the past two years to build up our reserves and ensure financial stability to continue our much needed services.

We will continue to build awareness of our services to more organisations to help ensure those higher levels of occupancy and use.

Diversion Scheme

As with previous years, the Diversion Scheme remains under constant review and development. We aim to bring additional police forces into the Diversion scheme, believing that this level of growth is manageable for the scheme. We will continue to advise forces on their approach to a two-tier Out of Court disposals system for alcohol and other drug offences and use our influence to attract more business across our suite of courses. We will also particularly increase the use of e-learning in our courses which continues to bring a new dimension to our work.

As demand for the service grows, we are identifying the need for additional IT capacity as well as additional functionality and online access beyond developments made during the past year.

Training

We will continue to offer bespoke training and deliver sessions in schools as resources allows. We will explore opportunities for external funding to increase our capabilities in this area. E-learning will continue to be available and we aim to keep the cost of this to a minimum to allow greater access whilst still covering the cost of the system used.

Finance and Operations

Druglink will continue to maintain its quality programmes such as Investors in People. It will continue to hold staff events for the organisation to continue to consider and agree clear organisational values and how these are shared. We will encourage staff involvement in these quality programmes through the creation of quality champions within individual services.

Ongoing reviews of IT contracts for services will continue to ensure the charity receives best value as well as service from its suppliers.

All Druglink marketing materials and websites will continue to be reviewed to ensure Druglink remains relevant in the field of substance misuse and recovery. We want to ensure that we are providing the right information to potential clients as well as to the general public who may want to support the work of the charity. Druglink aspires to be an accessible service removing the stigma and preconceptions associated with addiction or substance misuse. The senior management team continues to be tasked during this current financial year to keep all areas under review for cost savings and efficiencies from staff costs to suppliers.

Page 10

DRUGLINK

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31ST MARCH 2022

STRUCTURE, GOVERNANCE AND MANAGEMENT

Governing document

The Charity's aims and objectives are regulated by its Memorandum and Articles of Association dated 28 September 1986 incorporating the Charity (Registered Number 295384) as a Company Limited by Guarantee and updated and approved by the Trustees on 17 November 2006 and approved by the Charity Commission on 24 May 2009.

Its main objectives are to:

The main activities for the year continued to focus on the promotion, education and prevention of the misuse of drugs and the rehabilitation of those misusing substances. Strategies employed to achieve these aims included:

- Providing a range of services which are reflective of relevant quality standards and address the potential problems experienced by substance misuse.

Recruitment and Appointment of New Trustees

When the management committee recognise that the recruitment of a new staff member is required, a job description is completed. This is circulated where the management committee considers it necessary to attract someone with the necessary skills for the particular job. Applicants submit their details which are scrutinised by the appropriate committee members and a short list is selected for interview. Such candidates are interviewed and if appropriate an offer is made to the most suitable candidate on an equal opportunities basis.

Pay and Remuneration

Annual reviews of pay and remuneration for key members of staff are undertaken. Different factors are taken into account when considering pay and remuneration for key staff and these include:

Any changes to pay and remuneration for the key staff of the charity are approved by the Board as part of the budget setting exercise. Should there be changes during the financial year, then approvals are made at the appropriate Board meetings and recorded in the minutes.

Appointment

The Trustees are mindful of the need to have balanced group of Trustees who can provide a wide range of skills. If they consider that new trustee is required, they investigate potential individuals they consider suitable for the role and if there is agreement amongst them make an approach to that individual. If they accept, they will be appointed a new trustee.

Page 11

DRUGLINK

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31ST MARCH 2022

STRUCTURE, GOVERNANCE AND MANAGEMENT Induction and training of new trustees

Upon appointment as a trustee, the individual is given details of the Charity and encouraged to attend courses applicable for trustees.

Risk management

The Trustees take an active role in assessing the risks associated with the operations of the charity together with financial risks associated with the running of the charity and investments made. Action is taken to minimise risks with appropriate training of staff members and internal policies and procedures.

TRUSTEES' RESPONSIBILITY STATEMENT

The Trustees (who are also the directors of Druglink for the purposes of company law) are responsible for preparing the Report of the Trustees and the Financial Statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the Company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing those financial statements, the Trustees are required to:

The Trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the charitable company and to enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

In so far as the Trustees are aware, there is no relevant audit information of which the charitable company's auditors are unaware, and the Trustees have taken all steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the auditors are aware of that information.

AUDITORS

The auditors, Haines Watts (Berkhamsted) Limited, will be proposed for re-appointment at the forthcoming Annual General Meeting.

Approved by order of the board of Trustees on ............................................. and signed on its behalf by:

........................................................................ Trustee

Page 12

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF DRUGLINK

Opinion

We have audited the financial statements of Druglink (the 'charitable company') for the year ended 31st March 2022 which comprise the Statement of Financial Activities, the Balance Sheet, the Cash Flow Statement and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The trustees are responsible for the other information. The other information comprises the information included in the Annual Report, other than the financial statements and our Report of the Independent Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Page 13

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF DRUGLINK

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the Report of the Trustees.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of trustees

As explained more fully in the Trustees' Responsibilities Statement, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the charitable company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Page 14

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF DRUGLINK

Our responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Independent Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. The objectives of our audit are to identify and assess the risks of material misstatement of the financial statements due to fraud and error; to obtain sufficient appropriate audit evidence regarding the assessed risks of material misstatement due to fraud or error; and to respond appropriately to those risks. Owing to the inherent limitations of an audit, there is an unavoidable risk that material misstatements in the financial statements may not be detected, even though the audit is properly planned and performed in accordance with the ISAs (UK).

In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, our procedures included the following:

There are inherent limitations in the audit procedures described above and the further removed non-compliance with laws and regulations are from the events and transactions reflected in the financial statements, the less likely we would become aware of it. Also, the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Independent Auditors.

Page 15

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF DRUGLINK

Use of our report

This report is made solely to the charitable company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Shaun Brownsmith FCA (Senior Statutory Auditor) for and on behalf of Haines Watts (Berkhamsted) Limited 4 Claridge Court Lower Kings Road Berkhamsted Hertfordshire HP4 2AF

Date: .............................................

Page 16

DRUGLINK

STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31ST MARCH 2022

Notes
INCOME AND ENDOWMENTS FROM
Donations and legacies
2
Charitable activities
Diversion
Central
Services
Housing
Oxygen
Coffee Ethics
Investment income
3
Total
EXPENDITURE ON
Funds
5
Charitable activities
6
Diversion
Central
Services
Housing
Oxygen
Training
Coffee Ethics
Total
NET INCOME/(EXPENDITURE)
RECONCILIATION OF FUNDS
Total funds brought forward
TOTAL FUNDS CARRIED FORWARD		 Unrestricted
funds
£
48,390
239,153
990
-
550,715
457,639
5,183
1
1,302,071
1,515
175,332
143,955
-
491,197
487,947
-
12,874
1,312,820
(10,749)
96,434
85,685		 Restricted
funds
£
245,219
-
-
45
-
-
-
-
245,264
-
-
-
245,024
-
-
-
-
245,024
240
-
240		 31/3/22
Total
funds
£
293,609
239,153
990
45
550,715
457,639
5,183
1
1,547,335
1,515
175,332
143,955
245,024
491,197
487,947
-
12,874
1,557,844
(10,509)
96,434
85,925		 31/3/21
Total
funds
£
182,948
217,863
17,503
-
547,380
513,823
5,140
3
1,484,660
(94)
106,437
145,329
182,633
350,509
490,074
17,038
9,267
1,301,193
183,467
(87,033)
96,434

The notes form part of these financial statements Page 17

DRUGLINK

BALANCE SHEET 31ST MARCH 2022

Notes
FIXED ASSETS
Tangible assets
12
CURRENT ASSETS
Debtors
13
Cash at bank and in hand
CREDITORS
Amounts falling due within one year
14
NET CURRENT ASSETS
TOTAL ASSETS LESS CURRENT
LIABILITIES
CREDITORS
Amounts falling due after more than one year
15
PROVISIONS FOR LIABILITIES
18
NET ASSETS/(LIABILITIES)
FUNDS
20
Unrestricted funds
Restricted funds
TOTAL FUNDS		 31/3/22
£
-
333,978
128,524
462,502
(344,690)
117,812
117,812
(31,667)
(220)
85,925
85,685
240
85,925		 31/3/21
£
1,262
214,913
166,395
381,308
(243,719)
137,589
138,851
(41,667)
(750)
96,434
96,434
-
96,434

These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime.

The financial statements were approved by the Board of Trustees and authorised for issue on ............................................. and were signed on its behalf by:

............................................. Trustee

The notes form part of these financial statements Page 18

DRUGLINK

CASH FLOW STATEMENT FOR THE YEAR ENDED 31ST MARCH 2022

Notes
Cash flows from operating activities
Cash generated from operations
1
Interest paid
Net cash (used in)/provided by operating activities
Cash flows from investing activities
Interest received
Net cash provided by investing activities
Cash flows from financing activities
New loans in year
Loan repayments in year
Net cash (used in)/provided by financing activities
Change in cash and cash equivalents in
the reporting period
Cash and cash equivalents at the
beginning of the reporting period
Cash and cash equivalents at the end of
the reporting period		 31/3/22
£
(11,119)
(920)
(12,039)
1
1
-
(25,833)
(25,833)
(37,871)
166,395
128,524		 31/3/21
£
136,911
(6)
136,905
3
3
50,000
(27,499)
22,501
159,409
6,986
166,395

The notes form part of these financial statements Page 19

DRUGLINK

NOTES TO THE CASH FLOW STATEMENT FOR THE YEAR ENDED 31ST MARCH 2022

1. RECONCILIATION OF NET (EXPENDITURE)/INCOME TO NET CASH FLOW FROM OPERATING ACTIVITIES

OPERATING ACTIVITIES
Net (expenditure)/income for the reporting period (as per the
Statement of Financial Activities)
Adjustments for:
Depreciation charges
Interest received
Interest paid
Provisions
Increase in debtors
Increase in creditors
Net cash (used in)/provided by operations		 31/3/22
£
(10,509)
1,262
(1)
920
(530)
(119,065)
116,804
(11,119)		 31/3/21
£
183,467
2,697
(3)
6
750
(60,271)
10,265
136,911

2. ANALYSIS OF CHANGES IN NET FUNDS

At 1/4/21 Cash flow At 31/3/22
£ £ £
Net cash
Cash at bank and in hand 166,395 (37,871) 128,524
166,395 (37,871) 128,524
Debt
Debts falling due within 1 year (25,833) 15,833 (10,000)
Debts falling due after 1 year (41,667) 10,000 (31,667)
(67,500) 25,833 (41,667)
Total 98,895 (12,038) 86,857

The notes form part of these financial statements Page 20

DRUGLINK

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST MARCH 2022

1. ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention. The presentation currency of these financial statements is in Pounds Sterling.

Going concern

The financial statements have been prepared on a going concern basis. The trustees have reviewed and considered relevant information, including the annual budget and future cash flows in making their assessment.The trustees have tested their cash flow analysis to take into account the impact on their charity of possible scenarios, alongside the measures that they can take to mitigate the impact. Based on these assessments, given the measures that could be undertaken to mitigate the current adverse conditions, and the current resources available, the trustees have concluded that they can continue to adopt the going concern basis in preparing the annual report and accounts.

Income

Income is recognised when the Charity has entitlement to the funds, any performance indicators attached to the item(s) of income have been met, it is probable that the income will be received, and the amount can be measured reliably.

Donations are recognised in full in the Statement of Financial Activities when entitled, receipt is probable and when the amount can be quantified with reasonable accuracy. Gift aid receivable is included when claimable.

Grant income is credited to the Statement of Financial Activities when received or receivable whichever is earlier, unless the grant relates to a future year, in which case it is deferred. Income from charitable activities is credited to the Statement of Financial Activities when received or receivable whichever is earlier, unless it relates to a specific future year or event, in which case it is deferred.

Expenditure

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably.

All expenditure is accounted for on an accruals basis and has been included under expense categories that aggregate all costs for allocation to activities.

Indirect costs, including governance costs, which cannot be directly attributed to activities, are allocated proportionate to direct costs allocated to each project area.

Tangible fixed assets

Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost of fixed assets, less their residual value, over their useful life, on a straight-line basis. The useful life used is:

Plant and machinery

Taxation

The charity is exempt from corporation tax on its charitable activities.

Fund accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of theTrustees.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

The notes form part of these financial statements

Part 21

DRUGLINK

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31ST MARCH 2022

1. ACCOUNTING POLICIES - continued

Fund accounting

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to the Statement of Financial Activities on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The charitable company operates a defined contribution pension scheme. Contributions payable to the charitable company's pension scheme are charged to the Statement of Financial Activities in the period to which they relate.

2. DONATIONS AND LEGACIES

Gifts
Donations
Grants
3.
INVESTMENT INCOME
Deposit account interest
4.
INCOME FROM CHARITABLE ACTIVITIES
Activity
Other income
Diversion
Coronavirus Job Retention
Scheme
Diversion
Other income
Central
Coronavirus Job Retention
Scheme
Central
Other income
Services
Other income
Housing
Coronavirus Job Retention
Scheme
Housing
Other income
Oxygen
Other income
Coffee Ethics
Coronavirus Job Retention
Scheme
Coffee Ethics

The notes form part of these financial statements Page 22

DRUGLINK

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31ST MARCH 2022

5. FUNDS

Other trading activities

Bad debts
Interest payable and similar charges
CHARITABLE ACTIVITIES COSTS
Diversion
Central
Services
Housing
Oxygen
Coffee Ethics
SUPPORT COSTS
Central
Services
Housing
Oxygen
Support costs, included in the above, are as follows:
Rent
Auditors' remuneration
Accountancy fees
Legal fees		 Direct
Costs
£
175,332
133,466
240,479
288,648
455,607
12,874
1,306,406
Finance
£
-
4,545
202,549
32,340
239,434
Central
£
-
6,930
2,250
1,309
10,489		 31/3/22
£
595
920
1,515
Support
costs (see
note 7)
£
-
10,489
4,545
202,549
32,340
-
249,923
Governance
costs
£
10,489
-
-
-
10,489
Services
£
4,545
-
-
-
4,545		 31/3/21
£
(100)
6
(94)
Totals
£
175,332
143,955
245,024
491,197
487,947
12,874
1,556,329
Totals
£
10,489
4,545
202,549
32,340
249,923
Housing
£
202,549
-
-
-
202,549

6. CHARITABLE ACTIVITIES COSTS

7. SUPPORT COSTS

The notes form part of these financial statements Page 23

DRUGLINK

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31ST MARCH 2022

7. SUPPORT COSTS - continued

SUPPORT COSTS - continued
Rent
Auditors' remuneration
Accountancy fees
Legal fees		 Oxygen
£
32,340
-
-
-
32,340		 31/3/22
Total
activities
£
239,434
6,930
2,250
1,309
249,923		 31/3/21
Total
activities
£
215,690
6,930
8,364
-
230,984

8. NET INCOME/(EXPENDITURE)

Net income/(expenditure) is stated after charging/(crediting):

31/3/22 31/3/21
£ £
Auditors' remuneration 6,930 6,930
Depreciation - owned assets 1,262 2,698
Hire of plant and machinery 1,338 1,180
Other operating leases 84,000 84,000

9. TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 31 March 2022 nor for the year ended 31 March 2021.

Trustees' expenses

There were no trustees' expenses paid for the year ended 31 March 2022 nor for the year ended 31 March 2021.

10. STAFF COSTS

STAFF COSTS
31/3/22 31/3/21
£ £
Wages and salaries 713,475 549,140
Social security costs 55,296 42,118
Other pension costs 9,169 7,173
777,940 598,431
The average monthly number of employees during the year was as follows:
31/3/22 31/3/21
Average number of staff 34 27
The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 wa
31/3/22 31/3/21
£60,001 - £70,000 1 -

The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was:

The notes form part of these financial statements Page 24

DRUGLINK

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31ST MARCH 2022

11.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted
funds
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
949
Charitable activities
Diversion
217,863
Central
17,503
Housing
547,380
Oxygen
513,823
Coffee Ethics
5,140
Investment income
3
Total
1,302,661
EXPENDITURE ON
Funds
(94)
Charitable activities
Diversion
106,437
Central
145,329
Services
-
Housing
324,344
Oxygen
490,074
Training
-
Coffee Ethics
9,267
Total
1,075,357
NET INCOME/(EXPENDITURE)
227,304
RECONCILIATION OF FUNDS
Total funds brought forward
(130,870)
TOTAL FUNDS CARRIED FORWARD
96,434
Restricted
funds
£
181,999
-
-
-
-
-
-
181,999
-
-
-
182,633
26,165
-
17,038
-
225,836
(43,837)
43,837
-		 Total
funds
£
182,948
217,863
17,503
547,380
513,823
5,140
3
1,484,660
(94)
106,437
145,329
182,633
350,509
490,074
17,038
9,267
1,301,193
183,467
(87,033)
96,434

The notes form part of these financial statements Page 25

DRUGLINK

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31ST MARCH 2022

12. TANGIBLE FIXED ASSETS

COST
At 1st April 2021 and 31st March 2022
DEPRECIATION
At 1st April 2021
Charge for year
At 31st March 2022
NET BOOK VALUE
At 31st March 2022
At 31st March 2021
13.
DEBTORS
Amounts falling due within one year:
Trade debtors
Other debtors
Accrued income
Prepayments
Amounts falling due after more than one year:
Other debtors
Aggregate amounts
14.
CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Bank loans and overdrafts (see note 16)
Other loans (see note 16)
Trade creditors
Social security and other taxes
Other creditors
Accruals and deferred income		 31/3/22
£
203,491
14,847
47,060
43,080
308,478
25,500		 Plant and
machinery
£
264,998
263,736
1,262
264,998
-
1,262
31/3/21
£
84,345
14,009
45,136
45,923
189,413
25,500
214,913
31/3/21
£
8,333
17,500
122,479
13,038
3,872
78,497
243,719
333,978
31/3/22
£
10,000
-
107,232
14,174
1,957
211,327
344,690

The notes form part of financial statements Page 26

DRUGLINK

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31ST MARCH 2022

15. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

31/3/22
£
Bank loans (see note 16)
31,667
16.
LOANS
An analysis of the maturity of loans is given below:
31/3/22
£
Amounts falling due within one year on demand:
Bank loan
10,000
Other loan
-
10,000
Amounts falling between one and two years:
Bank Loan
10,000
Amounts falling due between two and five years:
Bank loan - 2-5 years
21,667
Amounts falling due in more than five years:
Repayable by instalments:
Bank loan more 5 yr by instal
-
17.
LEASING AGREEMENTS
Minimum lease payments under non-cancellable operating leases fall due as follows:
31/3/22
£
Within one year
84,000
Between one and five years
336,000
In more than five years
270,750
690,750		 31/3/21
£
41,667
31/3/21
£
8,333
17,500
25,833
10,000
30,000
1,667
31/3/21
£
84,000
336,000
354,750
774,750

The operating leases relates to the sale and lease back of Nascent House and the lease of 89 Castle Street.

18. PROVISIONS FOR LIABILITIES

PROVISIONS FOR LIABILITIES
31/3/22 31/3/21
£ £
Provisions 220 750

The notes form part of these financial statements Page 27

DRUGLINK

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31ST MARCH 2022

19. ANALYSIS OF NET ASSETS BETWEEN FUNDS

Unrestricted
funds
£
Fixed assets
-
Current assets
462,262
Current liabilities
(344,690)
Long term liabilities
(31,667)
Provision for liabilities
(220)
85,685
MOVEMENT IN FUNDS
At 1/4/21
£
Unrestricted funds
General fund
96,434
Diversion
-
Coffee Ethic
-
Housing
-
96,434
Restricted funds
Services
-
TOTAL FUNDS
96,434		 Restricted
funds
£
-
240
-
-
-
240
Net
movement
in funds
£
(167,130)
63,819
(7,690)
100,252
(10,749)
240
(10,509)		 31/3/22
Total
funds
£
-
462,502
(344,690)
(31,667)
(220)
85,925
Transfers
between
funds
£
70,696
-
7,690
(78,386)
-
-
-		 31/3/21
Total
funds
£
1,262
381,308
(243,719)
(41,667)
(750)
96,434
At
31/3/22
£
-
63,819
-
21,866
85,685
240
85,925

20. MOVEMENT IN FUNDS

Net movement in funds, included in the above are as follows:

Unrestricted funds
General fund
Diversion
Coffee Ethic
Housing
Restricted funds
Services
TOTAL FUNDS		 Incoming
resources
£
466,284
239,154
5,184
591,449
1,302,071
245,264
1,547,335		 Resources
expended
£
(633,414)
(175,335)
(12,874)
(491,197)
(1,312,820)
(245,024)
(1,557,844)		 Movement
in funds
£
(167,130)
63,819
(7,690)
100,252
(10,749)
240
(10,509)

The notes form part of these financial statements Page 28

DRUGLINK

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31ST MARCH 2022

20. MOVEMENT IN FUNDS - continued

Comparatives for movement in funds

At 1/4/20
£
Unrestricted funds
General fund
(202,832)
Diversion
12,219
Coffee Ethic
(230,119)
Housing
289,862
(130,870)
Restricted funds
Services
26,799
Training
17,038
43,837
TOTAL FUNDS
(87,033)
Comparative net movement in funds, included in the above are a
Unrestricted funds
General fund
Diversion
Coffee Ethic
Housing
Restricted funds
Housing
Services
Training
TOTAL FUNDS		 Net
movement
in funds
£
667,356
(106,442)
(9,267)
(324,343)
227,304
(26,799)
(17,038)
(43,837)
183,467
s follows:
Incoming
resources
£
1,302,662
(1)
-
-
1,302,661
26,165
155,834
-
181,999
1,484,660

The notes form part of these financial statements Page 29

DRUGLINK

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31ST MARCH 2022

21. RELATED PARTY DISCLOSURES

During this and the previous year, Druglink rented six properties from a Trustee, Ray Knowles. The total rent paid was £89,355 (2021: £81,600).

During this and the previous year a Trustee, David Swarbrick, provided Druglink with interest free loans for which there was a loan agreement with a repayment plaan. The year end balance was £Nil (2021: £17,500).

The notes form part of these statements Page 30

DRUGLINK

DETAILED STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31ST MARCH 2022

INCOME AND ENDOWMENTS
Donations and legacies
Gifts
Donations
Grants
Investment income
Deposit account interest
Charitable activities
Other income
Coronavirus Job Retention Scheme
Total incoming resources
EXPENDITURE
Other trading activities
Bad debts
Bank loan interest
Charitable activities
Wages
Social security
Pensions
Hire of plant and machinery
Other operating leases
Rates and water
Insurance
Light and heat
Telephone
Postage and stationery
Advertising
Sundries
Bank charges
Trainer fees
Venue hire
Travel costs
Software
Staff costs
Professional fees
Repairs and maintenance
Carried forward		 31/3/22
£
60
6,396
287,153
293,609
1
1,251,619
2,106
1,253,725
1,547,335
595
920
1,515
713,475
55,296
9,169
1,338
84,000
34,383
14,627
58,861
17,797
26,132
1,468
20,813
7,539
33,708
7,839
11,525
37,280
4,082
6,805
80,664
1,226,801		 31/3/21
£
-
1,698
181,250
182,948
3
1,272,955
28,754
1,301,709
1,484,660
(100)
6
(94)
549,140
42,118
7,173
1,180
84,000
30,759
13,441
45,125
15,797
12,635
153
21,418
6,928
5,560
(645)
6,915
12,602
13,981
23,200
78,033
969,513

This page does not form part of the statutory financial statements Page 31

DRUGLINK

DETAILED STATEMENT OF FINANCIAL ACTIVITIES
FOR THE YEAR ENDED 31ST MARCH 2022
31/3/22
£
Charitable activities
Brought forward
1,226,801
Bad debts
-
Subscriptions
7,955
Equipment
21,673
Other establishment costs
16,202
Clients activities
3,879
Counsellor fees
1,590
Supplies for clients
3,146
Drug testing and doctors' fees
23,898
Plant and machinery
1,262
1,306,406
Support costs
Finance
Rent
239,434
Governance costs
Auditors' remuneration
6,930
Accountancy fees
2,250
Legal fees
1,309
10,489
Total resources expended
1,557,844
Net (expenditure)/income
(10,509)		 31/3/21
£
969,513
(708)
14,660
30,181
12,176
3,033
4,677
171
33,903
2,697
1,070,303
215,690
6,930
8,364
-
15,294
1,301,193
183,467

This page does not form part of the statutory financial statements Page 32